Regulation 15 Effect of preliminary consent
Subject to paragraph (2), where the applicant has been finally granted preliminary consent, the FHSA shall grant an application under regulation 4(2) provided that—
the date specified for inclusion in the pharmaceutical list falls within the period referred to in regulation 14(5);
the pharmaceutical services which it is proposed to provide are the same as those specified in the application for preliminary consent; and
the premises specified in the application have the same location as that in respect of which the preliminary consent was granted.
Where sub-paragraphs (a) and (b) of paragraph (1) are satisfied but the premises specified in the application have a different location from that in respect of which preliminary consent was granted, the FHSA shall treat the application as though it were an application under regulation 4(2)(b) to change the location of the premises.
The grant of an application under this regulation shall be subject to any conditions imposed under regulation 12(15) or 13(13)(b) in relation to the final grant of the corresponding preliminary consent.